168 related articles for article (PubMed ID: 2772268)
1. Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency.
Jansen JB; Jebbink MC; Mulders HJ; Lamers CB
Regul Pept; 1989; 25(3):333-42. PubMed ID: 2772268
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
[TBL] [Abstract][Full Text] [Related]
3. Postprandial cholecystokinin response in patients with chronic pancreatitis in treatment with oral substitutive pancreatic enzymes.
Garcés MC; Gómez-Cerezo J; Codoceo R; Grande C; Barbado J; Vázquez JJ
Dig Dis Sci; 1998 Mar; 43(3):562-6. PubMed ID: 9539652
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
Gielkens HA; Eddes EH; Vecht J; van Oostayen JA; Lamers CB; Masclee AA
J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
[TBL] [Abstract][Full Text] [Related]
5. Postprandial release of cholecystokinin after duodenum-preserving total pancreatectomy is independent of intraluminal pancreatic protease activity in dogs.
Guicherit OR; Gooszen HG; Jansen JB; van der Burg MP; Lamers CB
Digestion; 1990; 47(4):226-31. PubMed ID: 2100272
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis.
Herzig KH; Domagk J; Nustede R; Stern M; Bewig B; Cichy WK; Fölsch UR
Scand J Gastroenterol; 1997 Apr; 32(4):315-9. PubMed ID: 9140152
[TBL] [Abstract][Full Text] [Related]
7. Role of cholecystokinin in bombesin-stimulated pancreatic enzyme secretion in conscious rats.
de Jong AJ; Jansen JB; Hafkenscheid JC; Lamers CB
Pancreas; 1990 Mar; 5(2):194-9. PubMed ID: 2315296
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunoneutralisation of cholecystokinin on bombesin-stimulated pancreatic enzyme secretion in the rat.
Lamers CB; de Jong AJ; Hafkenscheid JC; Jansen JB
Regul Pept; 1989 Dec; 26(3):297-304. PubMed ID: 2623193
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of neurotensin and CCK in patients with chronic pancreatitis with and without enzyme substitution.
Nustede R; Köhler H; Fölsch UR; Schafmayer A
Pancreas; 1991 May; 6(3):260-5. PubMed ID: 1713670
[TBL] [Abstract][Full Text] [Related]
10. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
[TBL] [Abstract][Full Text] [Related]
11. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Jansen JB; Jebbink MC; Douglas BR; Lamers CB
Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
[TBL] [Abstract][Full Text] [Related]
12. No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.
Nakamura T; Takebe K; Kudoh K; Ishii M; Imamura K; Kikuchi H; Kasai F; Tandoh Y; Yamada N; Arai Y
Int J Pancreatol; 1995 Feb; 17(1):29-35. PubMed ID: 8568332
[TBL] [Abstract][Full Text] [Related]
13. Plasma CCK levels in patients with pancreatic insufficiency.
Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
15. Reversible gall bladder dysfunction in severe pancreatic insufficiency.
Masclee AA; Jansen JB; Corstens FH; Lamers CB
Gut; 1989 Jun; 30(6):866-72. PubMed ID: 2753411
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
[TBL] [Abstract][Full Text] [Related]
17. Plasma cholecystokinin levels in patients with chronic pancreatitis.
Schafmayer A; Becker HD; Werner M; Fölsch UR; Creutzfeldt W
Digestion; 1985; 32(2):136-9. PubMed ID: 4043564
[TBL] [Abstract][Full Text] [Related]
18. Gallbladder motility after duodenum-preserving resection of the head of the pancreas.
Eddes EH; Masclee AM; Gielkens HA; Gooszen HG; Lamers CB
Scand J Gastroenterol; 1997 Sep; 32(9):878-83. PubMed ID: 9299664
[TBL] [Abstract][Full Text] [Related]
19. Release of radioimmunologic cholecystokinin in human subjects.
Becker HD; Werner M; Schafmayer A
Am J Surg; 1984 Jan; 147(1):124-9. PubMed ID: 6691538
[TBL] [Abstract][Full Text] [Related]
20. [Plasma cholecystokinin level in chronic pancreatitis].
Mössner J; Back T; Regner U; Fischbach W
Z Gastroenterol; 1989 Aug; 27(8):401-5. PubMed ID: 2609704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
